Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Encoded Therapeutics is a biotechnology company developing genetic medicines for neurological disorders and other diseases.
EliseAI is an AI-driven company that offers automation, streamlining workflows, and unique needs of housing and healthcare operations.
Within turns how a company actually works into structured, AI-ready context, then puts agents to work alongside people. Formerly Klarity.
Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.
One Biosciences leverages single-cell technologies to identify new therapeutics for difficult-to-treat diseases.
Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.
Abata Therapeutics develops regulatory T cell (Treg) therapies for treating autoimmune diseases including progressive multiple sclerosis.
Amount is a digital technology company that accelerates digital transformation for financial institutions.
Finastra provides the broadest portfolio of financial services software.
FireHydrant is an incident management tool that helps companies recover from IT disasters more quickly.
BRIUS is a healthcare company that focuses in the orthodontics and medical device industry.
Pretzel Therapeutics mission is to develop groundbreaking therapies to reverse mitochondrial dysfunction through mitochondrial biology.
Erasca is a developer of oncology drugs intended to provide precision oncology options.
City Therapeutics is a biopharmaceutical company focused on developing RNA interference (RNAi)-based medicines for a range of diseases.
Viseon is a privately held medical device company committed to developing proprietary technology.
Engine Biosciences is a biotech company that applies machine learning to genomics for drug discovery.
Averna Therapeutics develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.
Osanni Bio is a biotechnology company developing therapies aimed at preventing and reversing blindness caused by retinal diseases.
HappyVore cultivates a passion for taste, the real, the healthy, and the impact on the planet.
Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.
Pioneering Potent, Safer Cell Therapy in and Beyond Oncology
Cyclerion Therapeutics harnesses the potential of soluble guanylate cyclase (sGC) pharmacology.
Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.
ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.
Invus has invested in 108 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Invus's top investment sectors include Biotechnology, Therapeutics, Health Care, Life Science, Oncology. The firm invests across 41 different industry categories.
Among tracked funding rounds, Finastra received $5.3B in a Debt Financing round. Invus's total known invested capital is $5.5B.
Invus's average investment size is $81.9M across its portfolio of 108 companies.
Recent Invus portfolio additions include Encoded Therapeutics, EliseAI, Within, Tyra Biosciences, One Biosciences. These companies were founded in 2020 or later.